🚀 VC round data is live in beta, check it out!
- Public Comps
- DocCheck
DocCheck Valuation Multiples
Discover revenue and EBITDA valuation multiples for DocCheck and similar public comparables like MemeStrategy, Research Solutions, Tam Development, Praveg and more.
DocCheck Overview
About DocCheck
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Founded
1990
HQ

Employees
248
Website
Financials (FY)
EV
$57M
DocCheck Financials
DocCheck reported last fiscal year revenue of $62M and EBITDA of $12M.
In the same fiscal year, DocCheck generated $42M in gross profit, $12M in EBITDA, and $6M in net income.
DocCheck P&L
In the most recent fiscal year, DocCheck reported revenue of $62M and EBITDA of $12M.
DocCheck expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $62M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $42M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 67% | XXX | XXX | XXX |
| EBITDA | — | XXX | $12M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 12% | XXX | XXX | XXX |
| Net Profit | — | XXX | $6M | XXX | XXX | XXX |
| Net Margin | — | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
DocCheck Stock Performance
DocCheck has current market cap of $76M, and enterprise value of $57M.
Market Cap Evolution
DocCheck's stock price is $14.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $57M | $76M | 1.1% | XXX | XXX | XXX | $1.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDocCheck Valuation Multiples
DocCheck trades at 0.9x EV/Revenue multiple, and 4.8x EV/EBITDA.
DocCheck Financial Valuation Multiples
As of March 22, 2026, DocCheck has market cap of $76M and EV of $57M.
Equity research analysts estimate DocCheck's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DocCheck has a P/E ratio of 12.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $76M | XXX | $76M | XXX | XXX | XXX |
| EV (current) | $57M | XXX | $57M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 7.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.4x | XXX | XXX | XXX |
| P/E | — | XXX | 12.4x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 7.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DocCheck Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


DocCheck Margins & Growth Rates
DocCheck's revenue in the last fiscal year grew by 1%.
DocCheck Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 7% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
DocCheck Public Comps
See public comps and valuation multiples for other Advertising & Marketing and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MemeStrategy | XXX | XXX | XXX | XXX | XXX | XXX |
| Research Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Tam Development | XXX | XXX | XXX | XXX | XXX | XXX |
| Praveg | XXX | XXX | XXX | XXX | XXX | XXX |
| ezCaretech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DocCheck M&A Activity
DocCheck acquired XXX companies to date.
Last acquisition by DocCheck was on XXXXXXXX, XXXXX. DocCheck acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DocCheck
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDocCheck Investment Activity
DocCheck invested in XXX companies to date.
DocCheck made its latest investment on XXXXXXXX, XXXXX. DocCheck invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DocCheck
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DocCheck
| When was DocCheck founded? | DocCheck was founded in 1990. |
| Where is DocCheck headquartered? | DocCheck is headquartered in Germany. |
| How many employees does DocCheck have? | As of today, DocCheck has over 248 employees. |
| Is DocCheck publicly listed? | Yes, DocCheck is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of DocCheck? | DocCheck trades under AJ91 ticker. |
| When did DocCheck go public? | DocCheck went public in 2000. |
| Who are competitors of DocCheck? | DocCheck main competitors are MemeStrategy, Research Solutions, Tam Development, Praveg. |
| What is the current market cap of DocCheck? | DocCheck's current market cap is $76M. |
| What is the current revenue of DocCheck? | DocCheck's last fiscal year revenue is $62M. |
| What is the current EV/Revenue multiple of DocCheck? | Current revenue multiple of DocCheck is 0.9x. |
| Is DocCheck profitable? | No, DocCheck is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.